Using Machine Learning to Forecast Visual Outcomes in Wet AMD
Predicting Refractive Outcomes of Cataract Surgery
Quantifying Quality of Life in Cases of Good Unilateral Vision
U.S. Experience: Real-World Outcomes in Wet AMD
Treating Exudative AMD With Bevacizumab Is Highly Cost-Effective
Parents of Preterm Infants Have Limited Knowledge of ROP
Type of Health Insurance and Access to Eye Care
Unverifiable Publications on Ophthalmology Residency Applications
Lampalizumab Ineffective for Geographic Atrophy
Refractive Error After Cataract Surgery: New Risk Factors Identified
Off-Label Use of Juvéderm Voluma XC in Infraorbital Hollows
Look out for the early signs and symptoms of this rare disease.
Explore TEPEZZA now.
TEPEZZA is a trademark owned by or licensed to Horizon.© 2021 Horizon Therapeutics plc P-TEP-01315 08/21
Public & Patients
Museum of the Eye